An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
Ivan Urits
Gavin Clark
Daniel An
Bredan Wesp
Rebecca Zhou
Ariunzaya Amgalan
Amnon A. Berger
Hisham Kassem
Anh L. Ngo
Alan Kaye
Rachel J. Kaye
Elyse M. Cornett
Omar Viswanath
10.6084/m9.figshare.11890503.v1
https://adisjournals.figshare.com/articles/figure/An_Evidence-Based_Review_of_Fremanezumab_for_the_Treatment_of_Migraine/11890503
<p></p><p>The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.<b>
</b></p><br><p></p>
2020-03-13 15:40:23
Chronic pain
CGRP
Fremanezumab
Headache
Migraine
Monoclonal antibody